16 October 2024
Oxford Nanopore Technologies plc (the "Company")
Release of shares under legacy Founder LTIP - Director/PDMR Notification
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
In June 2021, the Company granted a one-off legacy conditional performance-related award under the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021 approved by shareholders prior to the Company's initial public offering ("Founder LTIP").
As previously disclosed, a proportion of this award vested in October 2022 subject to a post-vesting holding period ending on the second anniversary of the vesting date. On 14 October 2024, 4,231,034 ordinary shares of £0.0001 each ("Ordinary Shares") were released under the Founder LTIP to Gordon Sanghera, a Director and a Person Discharging Managerial Responsibilities.
On 15 October 2024, Gordon Sanghera then sold sufficient Ordinary Shares to meet his tax liabilities in respect of the release of his award, with the balance of Ordinary Shares retained.
Gordon Sanghera - release of the award granted under the Founder LTIP
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Gurdial (Gordon) Sanghera | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of £0.0001 each
GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Release of the award granted under the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021 | ||||
| c) | Price(s) and volumes(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price |
4,231,034 Nil | ||||
| e) | Date of the transaction | 14 October 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
Gordon Sanghera - Sale of shares to satisfy tax under the Founder LTIP
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Gurdial (Gordon) Sanghera | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of £0.0001 each
GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Sale of sufficient shares to fund the tax liabilities. Balance of shares retained. | ||||
| c) | Price(s) and volumes(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price |
1,993,571
£2,824,112.61 | ||||
| e) | Date of the transaction | 15 October 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
-ENDS-
Enquiries:
Investors
Media
OxfordNanoporeTechnologies@teneo.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
